Inequalities in health outcomes impose substantial human and economic costs on all
societies—and the relation between early adversity and lifelong well-being presents a rich …

The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial
infarction (AMI) does not decrease regardless of implementation of new technologies …

This Technical Report was retired November 2021. Advances in fields of inquiry as diverse
as neuroscience, molecular biology, genomics, developmental psychology, epidemiology …

Extensive evidence that personal experiences and environmental exposures are embedded
biologically (for better or for worse) and the cumulative knowledge of more than four …

Background—Prior studies have suggested using a panel of biomarkers that measure
diverse biological processes as a prognostic tool in chronic heart failure. Whether this …

Although inflammation is a physiologic response designed to protect us from infection, when
unchecked and ongoing it may cause substantial harm. Both chronic heart failure (CHF) and …

Background Heart failure (HF) is a complex clinical syndrome characterized by impaired
cardiac function and poor exercise tolerance. Enhanced inflammation is associated with …

Although substantial improvements have been made in majority of cardiac disorders, heart
failure (HF) remains a major health problem, with both increasing incidence and prevalence …

Aims Plasma concentrations of high-sensitivity C-reactive protein (hsCRP) are often raised
in chronic heart failure (CHF) and might indicate inflammatory processes that could be a …

Objective Stage B, asymptomatic heart failure (HF) presents a therapeutic window for
attenuating disease progression and development of HF symptoms, and improving quality of …